Sograzepide
Modify Date: 2024-01-02 00:26:49
Sograzepide structure
|
Common Name | Sograzepide | ||
|---|---|---|---|---|
| CAS Number | 155488-25-8 | Molecular Weight | 498.57600 | |
| Density | 1.25g/cm3 | Boiling Point | 723.049ºC at 760 mmHg | |
| Molecular Formula | C28H30N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 391.086ºC | |
Use of SograzepideSograzepide (Netazepide;YF476) is a gastrin/cholecystokinin 2 receptor (CCK2) antagonist. |
| Name | 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea |
|---|---|
| Synonym | More Synonyms |
| Description | Sograzepide (Netazepide;YF476) is a gastrin/cholecystokinin 2 receptor (CCK2) antagonist. |
|---|---|
| Related Catalog | |
| Target |
Gastrin/cholecystokinin 2 receptor (CCK2)[1] |
| References |
| Density | 1.25g/cm3 |
|---|---|
| Boiling Point | 723.049ºC at 760 mmHg |
| Molecular Formula | C28H30N6O3 |
| Molecular Weight | 498.57600 |
| Flash Point | 391.086ºC |
| Exact Mass | 498.23800 |
| PSA | 119.28000 |
| LogP | 4.04840 |
| Storage condition | 2-8℃ |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide CAS#:155488-25-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
![1,3-dihydro-5-(pyridin-2-yl)-3(R,S)-[(benzyloxycarbonyl)-amino]-2H-1,4-benzodiazepin-2-one structure](https://www.chemsrc.com/caspic/277/152665-84-4.png)
![3-[N-(tert-butoxycarbonyl)-N-methyl-amino]phenyl isocyanate structure](https://www.chemsrc.com/caspic/170/168162-32-1.png)
![(R)-3-amino-1-(3,3-dimethyl-2-oxobutyl)-5-(pyridin-2-yl)-1H-benzo[e][1,4]diazepin-2(3H)-one structure](https://www.chemsrc.com/caspic/428/164343-31-1.png)
![benzyl (1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)carbamate structure](https://www.chemsrc.com/caspic/238/186086-59-9.png)
| Precursor 8 | |
|---|---|
| DownStream 0 | |
| UNII-HOU4I0G29C |
| YF-476 |
| Sograzepide |